Literature DB >> 9179920

Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery.

F Lyall1, A Young, F Boswell, J C Kingdom, I A Greer.   

Abstract

In view of the pathological placental features of pre-eclampsia and intrauterine growth restriction (IUGR), and the angiogenic effects of vascular endothelial growth factor (VEGF), the aim of this study was to determine the expression of VEGF in placentae from normal pregnancies and to compare the results with placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction (IUGR). ELISA was used to measure circulating VEGF immunoreactivity in umbilical vein serum samples and immunohistochemistry was used to determine tissue expression of the protein. Since VEGF is known to be upregulated by hypoxia, the expression pattern of VEGF would provide further clues to the oxygen status in the placentae at the time of sampling, presently a subject under great debate. The geometric mean concentration of VEGF immunoreactivity in umbilical vein serum of normal pregnant women was 112.46 pg/ml, in women with pre-eclampsia 50.23 pg/ml and in IUGR alone 175.35 pg/ml. These values were not statistically different from each other. Immunolocalization of VEGF in normal term villous placenta was observed in the syncytiotrophoblast with less intense staining in stromal cells. No qualitative differences in localization of staining between the groups (normal pregnancies, pre-eclampsia, pre-eclampsia plus IUGR, and IUGR) was found. Intensity of staining in stromal cells was also similar in the groups studied. However, intensity of VEGF immunostaining in syncytiotrophoblast was significantly reduced in the three pathological groups (P < 0.02) compared with the control group. These results suggest that reduced VEGF may be responsible, at least in part, for the impaired vascular development which occurs in these conditions. Our results are therefore not consistent with villous placental hypoxia at the time of sample collection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179920     DOI: 10.1016/s0143-4004(97)80061-6

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  23 in total

1.  Unexplained fetal death: another anti-angiogenic state.

Authors:  Jimmy Espinoza; Tinnakorn Chaiworapongsa; Roberto Romero; Yeon Mee Kim; Gi Jin Kim; Jyh Kae Nien; Juan Pedro Kusanovic; Offer Erez; Emmanuel Bujold; Luis F Gonçalves; Ricardo Gomez; Samuel Edwin
Journal:  J Matern Fetal Neonatal Med       Date:  2007-07

Review 2.  Placental angiogenesis in sheep models of compromised pregnancy.

Authors:  Lawrence P Reynolds; Pawel P Borowicz; Kimberly A Vonnahme; Mary Lynn Johnson; Anna T Grazul-Bilska; Dale A Redmer; Joel S Caton
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

3.  Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.

Authors:  Paul J Rozance; Gregory J Seedorf; Alicia Brown; Gates Roe; Meghan C O'Meara; Jason Gien; Jen-Ruey Tang; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

4.  Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia.

Authors:  Lauretta A Lacko; Micol Massimiani; Jenny L Sones; Romulo Hurtado; Silvia Salvi; Sergio Ferrazzani; Robin L Davisson; Luisa Campagnolo; Heidi Stuhlmann
Journal:  Mech Dev       Date:  2014-04-19       Impact factor: 1.882

5.  Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.

Authors:  Stacy Zamudio; Marcus Borges; Lourdes Echalar; Olga Kovalenko; Enrique Vargas; Tatiana Torricos; Abdulla Al Khan; Manuel Alvarez; Nicholas P Illsley
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

6.  Placental Underperfusion in a Rat Model of Intrauterine Growth Restriction Induced by a Reduced Plasma Volume Expansion.

Authors:  Karine Bibeau; Benoit Sicotte; Mélanie Béland; Menakshi Bhat; Louis Gaboury; Réjean Couture; Jean St-Louis; Michèle Brochu
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

7.  Intrauterine growth restriction and placental angiogenesis.

Authors:  Figen Barut; Aykut Barut; Banu Dogan Gun; Nilufer Onak Kandemir; Mehmet Ibrahim Harma; Muge Harma; Erol Aktunc; Sukru Oguz Ozdamar
Journal:  Diagn Pathol       Date:  2010-04-22       Impact factor: 2.644

8.  Placental hypoxia during placental malaria.

Authors:  Philippe Boeuf; Aimee Tan; Cleofe Romagosa; Jane Radford; Victor Mwapasa; Malcolm E Molyneux; Steven R Meshnick; Nicholas H Hunt; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

Review 9.  Cell migration from baby to mother.

Authors:  Gavin S Dawe; Xiao Wei Tan; Zhi-Cheng Xiao
Journal:  Cell Adh Migr       Date:  2007-01-28       Impact factor: 3.405

10.  Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.

Authors:  Victoria L Bills; Julia Varet; Ann Millar; Steven J Harper; Peter W Soothill; David O Bates
Journal:  Clin Sci (Lond)       Date:  2009-02       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.